06.01.2013 Views

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Commercialization of <strong>Agricultural</strong> Crop <strong>Biotechnology</strong> Products<br />

ment whereby conventional foods that have a history of safe use and consumption serve as a<br />

reference point <strong>for</strong> all safety testing.<br />

Testing <strong>for</strong> Food and Feed Safety<br />

Be<strong>for</strong>e any food crop produced using modern biotechnology can be marketed, the food<br />

product must undergo multiple years of rigorous safety assessment. In meeting stringent food<br />

safety requirements and standards, biotech foods are among the most thoroughly tested foods<br />

available. No other food crops in history—including foods currently available on grocers’<br />

shelves—have been tested and regulated as thoroughly as have foods developed through biotechnology.<br />

The safety of these foods is reviewed by regulatory agencies around the world according<br />

to internationally agreed-upon safety assessment guidelines.<br />

Data are collected systematically to assess food safety. The five main categories of testing<br />

are the safety of the new trait (most often the introduced protein), a comparison of the agronomic<br />

characteristics of the new plant to conventionally bred plants, also called “agronomic equivalence,”<br />

a comparison of the nutritional and biochemical composition of the new food with conventional<br />

food, also called “compositional equivalence,” the safety of the resulting food or feed<br />

established by comparative animal feeding studies, and the nutritional wholesomeness of the<br />

new food or feed established by testing in farm animals.<br />

Safety of the new trait (introduced protein). The safety assessment of products derived<br />

through biotechnology is unique in that the DNA inserted into the plant is well defined and well<br />

characterized. There<strong>for</strong>e, the newly produced protein(s) will be clearly identified. It is also<br />

important that the new substance produced in most biotech crops is a protein because very few<br />

proteins are harmful to humans and the specific protein(s) produced can be directly assessed <strong>for</strong><br />

safety.<br />

Each introduced protein is extensively characterized to understand how it functions and<br />

assess its similarity to proteins already present in foods. For example, the protein used to confer<br />

tolerance to Monsanto’s Roundup® herbicide, a member of a family of proteins present in most<br />

foods, has a well-defined function and is “generally recognized as safe” due to its history of safe<br />

consumption. The amount of the introduced protein is measured in key raw agricultural commodities<br />

to evaluate consumption levels and patterns. Comparison of the amino acid sequence of<br />

the introduced protein(s) to known toxins and allergens assures that the protein is neither a toxin<br />

nor an allergen nor closely related to either.<br />

Since proteins are a key component in food and are typically rapidly digested, the digestibility<br />

of the protein plays an important role in predicting safety. All proteins that have been introduced<br />

into biotech crops have been rapidly digested. To assess the potential to cause harm,<br />

animal toxicology studies are conducted with each new protein at high levels (thousands to hundreds<br />

of thousands of times greater than the highest predicted consumption). Not surprisingly,<br />

given the nature and digestibility of proteins used as well as the history of safe consumption, no<br />

adverse effects have been observed in these studies.<br />

The likelihood of the protein being an allergen or becoming an allergen is commonly<br />

assessed in detail according to international standards. The proteins used in commercial crops<br />

share none of the important characteristics that are common among known allergenic protein:<br />

none of these proteins is derived from allergenic sources or related to known allergens, the<br />

proteins are rapidly digested, and they are produced at low levels in the portions of the plant that<br />

are consumed. There<strong>for</strong>e, it has been concluded that these proteins pose no significant allergenic<br />

concerns.<br />

Agronomic equivalence. As part of the overall safety assessment of a crop developed via<br />

biotechnology, numerous agronomic and phenotypic parameters of the crop are compared with<br />

those of its conventional counterpart to assure that there are no meaningful changes caused by<br />

the trans<strong>for</strong>mation process or the introduced genes or trait. The morphology, yield, and other<br />

agronomic parameters are sensitive indicators of changes in the metabolism or physiology of the<br />

– 77 –

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!